Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Healthcare Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and... see more

Recent & Breaking News (TSXV:SBM)

Sirona Biochem to Present at BioNetwork East -- May 2015

Marketwired April 13, 2015

Sirona Biochem (V.SBM) scores positive results on anti-aging and regenerative medicine

Stockhouse Editorial March 24, 2015

Sirona Biochem Announces Positive Results With SBM-TFC-837 for Anti-Aging and Regenerative Medicine

Marketwired March 24, 2015

Sirona Biochem to Present at BIO Asia 2015 and Received Over $1.1 Million of Warrants Exercised

Marketwired March 12, 2015

Sirona Biochem Announces Successful Development of a Third Skin Lightener With Superior Safety and Efficacy

Marketwired March 11, 2015

Sirona Biochem: Positive Preclinical Toxicology Results for its SGLT2 Inhibitor Trigger Milestone Payment from Wanbang Biopharmaceuticals

Marketwired March 4, 2015

Sirona Biochem Appoints Dr. Martin Gleave to its Board of Directors

Marketwired February 25, 2015

Microcap Report: Gold Royalties (V.GRO) up 76% on Sandstorm takeover news

Stockhouse Editorial February 18, 2015

Sirona Biochem to Present New Results at BIO Europe 2015

Marketwired February 18, 2015

Sirona Biochem Invited to Present at Dose of the Valley Conference, San Francisco

Marketwired January 26, 2015

Sirona Biochem's Subsidiary TFChem Awarded Prestigious French Innovation Trophy

Marketwired December 2, 2014

Sirona Biochem Names Attila Hajdu as Chief Business Development Officer

Marketwired October 27, 2014

Sirona Biochem Announces Research Collaboration With Aegilops Applications

Marketwired October 20, 2014

Sirona Biochem: Obagi Medical Products Begins Manufacturing Scale-Up of Skin Lightening Agent

Marketwired October 7, 2014

Sirona Biochem Launches Anti-Aging Preclinical Studies

Marketwired September 22, 2014

Sirona Biochem Announces Positive Results of PK Study for Type 2 Diabetes

Marketwired September 3, 2014

Sirona Biochem Launches Global Awareness Campaign With Cousteau Ambassadors' Video

Marketwired August 21, 2014

Sirona Subsidiary, TFChem, Receives CDN$1.2 Million for Anti-Aging Project

Marketwired August 12, 2014

Microcap Report: Geodex Minerals (V.GXM), Sirona Biochem (V.SBM) active

Stockhouse Editorial July 31, 2014

Sirona Biochem (V.SBM), up 9%, successfully synthesizes anti-inflammatory compound

Stockhouse Editorial July 31, 2014